Aspergillosis in the immunocompromised: focus on treatment.
Aoun
M
M
Service de Médecine Interne, Clinique Henri Tagnon, Institut Jules Bordet, Bruxelles, Belgium.
Van der Auwera
P
P
Gèrain
J
J
Klastersky
J
J
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D001228:Aspergillosis / Q000276:immunology* / Q000628:therapy*; D001230:Aspergillus / Q000187:drug effects; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests
D017964:Itraconazole; D000666:Amphotericin B